LOGIN
Efficacy of combined teriparatide & denosumab vs. single-drug treatment for osteoporosis
February 2017
Efficacy of combined teriparatide & denosumab vs. single-drug treatment for osteoporosis
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
J Clin Endocrinol Metab. 2016 May;101(5):2023-30Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
94 postmenopausal women with osteoporosis were randomized to receive either teriparatide, denosumab, or a combination of the two treatments. The purpose of this study was to determine the effectiveness of combined therapy with regards to bone microarchitecture and estimated strength. Findings indicated that combination therapy of teriparatide and denosumab significantly improved most volumetric bo...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.